LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Gene Expression Profiling Drives Personalized Medicine Worldwide

Large amounts of data generated by gene expression profiling should increase implementation of information management tools, according to recent market research.   More...
17 Jun 2014

Rosetta and Moffitt Partner to Develop microRNA Cancer Diagnostic

Rosetta Genomics, a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, has entered into an agreement with Moffitt Cancer Center to advance the development and commercialization of Rosetta's thyroid neoplasia assay.   More...
16 Jun 2014

Sequenom Sells Bioscience Unit to Agena

Sequenom has sold its Bioscience business for up-to-USD 35.8 million to Agena Bioscience, which said it plans to expand clinical use of the Massarray System for mass spectrometry-based detection of nucleic acids.  More...
11 Jun 2014

Biodesign and Thermo Fisher to Rapidly Assess Absorbed Radiation Dose

The Biodesign Institute at Arizona State University is designing a multigene-assay panel and collaborating with Thermo Fisher Scientific to develop a real-time quantitative polymerase chain reaction-based assay system to rapidly assess absorbed radiation dose.   More...
11 Jun 2014

Memorial Sloan Kettering Cancer Center Partners with Quest Diagnostics

Memorial Sloan Kettering Cancer Center and Quest Diagnostics, a provider of diagnostic information services, have entered into joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.  More...
10 Jun 2014

Roche Acquires Genia Technologies, Strengthens Next Generation Sequencing Pipeline

Roche has acquired Genia Technologies, a privately held company, which is developing a single-molecule, semiconductor based DNA sequencing platform using nanopore technology.  More...
09 Jun 2014

Partnership with Lilly Expands Qiagen’s Personalized Healthcare Pipeline

Qiagen and Eli Lilly will codevelop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types.   More...
03 Jun 2014
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Collection and Transport System
PurSafe Plus®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Clinical Chemistry System
P780


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.